1. Market Research
  2. > Generic Drug Industry
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Atorvastatin Industry, September 2015 Market Reports from Top Publishers

You might be interested in: Drug, Pharmaceutical.


 
1-10 of 15 reports for Atorvastatin

Purchase Reports From Reputable Market Research Publishers

Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014

Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mixed Dyslipidemia Global Clinical Trials Review, H1, 2014" provides data on the Mixed Dyslipidemia ...

Atorvastatin, Ezetimibe  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Atorvastatin, Ezetimibe - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Atorvastatin  - Comprehensive patent search

Atorvastatin - Comprehensive patent search

  • $ 8 160
  • Company report
  • August 2015
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Atorvastatin, Ezetimibe  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Atorvastatin, Ezetimibe - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Amlodipine, Atorvastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Amlodipine, Atorvastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Atorvastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Atorvastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Atorvastatin, Ezetimibe  - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

Atorvastatin, Ezetimibe - Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)

  • $ 1 523
  • Industry report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Atorvastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Atorvastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Amlodipine, Atorvastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Amlodipine, Atorvastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Atorvastatin  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Atorvastatin - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • August 2015
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

About 900 reports for Atorvastatin

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry in China

  • January 2014
    28 pages
  • Cardiovascular ...  

    Atorvastatin  

    Indigestion Dru...  

  • China  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.